You need to be logged in to view this video
Biotech Bear Market Opportunities
Released on Wednesday, October 11, 2023•TECHNOLOGY
Our recent recommendation of THRN, up 68%, was just the tip of the M&A iceberg as both Big Pharma and Big Bio have bulging war chests.
John McCamant
Medical Technology Stock Letter,
Editor
John McCamant joined the leading investment newsletter, Medical Technology Stock Letter, as an associate editor in 1987 and was named editor in August 2000. He has spent over 35 years on the front lines of biotechnology investing. In his previous role as an equities analyst for the American Healthcare fund, Mr. McCamant uncovered investment opportunities and guided investment strategy.
Trending Now
Filter By Category
Filter By Keywords
Loading...